Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment
Status:
COMPLETED
Trial end date:
2024-09-05
Target enrollment:
Participant gender:
Summary
This study will be conducted to investigated the effect of decreased kidney function on PK and safety of GZR4 and to guide dosing recommendations in people with kidney impairment.